Status:
NOT_YET_RECRUITING
Outcomes of PRF on Septoplasty in Patient With Nasal Septal Deviation
Lead Sponsor:
Kafrelsheikh University
Conditions:
Nasal Septum; Deviation
Nasal Septal Srur
Eligibility:
All Genders
Up to 65 years
Phase:
NA
Brief Summary
The aim of this study is to assess the effectiveness of Platelet-Rich Fibrin (PRF) in improving postoperative healing, reducing complications, and enhancing functional outcomes in patients undergoing ...
Detailed Description
Septoplasty is a routine surgical intervention to correct nasal septal deviation, a major cause of nasal obstruction and chronic sinusitis. Despite advancements, postoperative complications-such as mu...
Eligibility Criteria
Inclusion
- Adults aged 18-65 years undergoing septoplasty. Presence of cartilage deviated nasal septum requiring repair. No contraindications to PRF therapy.
Exclusion
- History of coagulopathy or anticoagulant therapy. Active infection or systemic disease. Known hypersensitivity to PRF components. Previous nasal surgery Autoimmune or systemic inflammatory disease
Key Trial Info
Start Date :
June 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06996106
Start Date
June 1 2025
End Date
February 1 2026
Last Update
May 30 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.